Not applicableStudy completedNCT00689377
What this trial is testing
Prevalence of Peripheral Arterial Disease in Subject With a Moderate Risk of Cardiovascular (CV) Disease (CVD) in Primary Prevention
Who this might be right for
Peripheral Arterial Disease (PAD)Moderate Risk for Cardiovascular Disease (CVD)
AstraZeneca 9,000